Sector Alpha Week of 2026-08-05
20-quarter listed-company comparison

Chemicals - Speciality Stocks in India

Chemicals - Speciality: Jubilant Agri & Consumer Products Ltd owns the largest revenue base; Anlon Healthcare Ltd has the fastest current growth.

01 · the index people search for

Nifty Chemicals - Speciality Index — Constituents & Performance

The Chemicals - Speciality companies below are the listed Indian Chemicals - Speciality universe this page tracks — the same constituent set people search for as the Nifty Chemicals - Speciality index. Every figure is equal-weighted across those companies, so one large constituent cannot set the reading. Each number carries its own as-of date.

02 · the sector itself · before any single company

How has Chemicals - Speciality moved against NIFTY 500?

The line below covers up to 5.2 years and opens on the 5Y view; the buttons cut it shorter. Over the most recent two of them this sector is 459% ahead of NIFTY 500. Earnings across its companies grew 22% on average over the last four reported quarters. It has been ahead of NIFTY 500 on a rolling three-month view for 16 weeks running.

LEADER · ahead 16wPrice and the fundamentals both up4 of 5 companies ahead of NIFTY 500 by 5% or more over three months

RS ↑16w · 4/5 >200d (−1) · 4/5 lead (−1) · EPS 3/3↑

2005001000200020262025202420232022 2345333 TRAILING 12-MONTH EPS · 100 AT THE START0100113Jun 25Sep 25Dec 25Mar 26Jun 2025 · trailing 12-month earnings per share at 100, against 100 at the start · no comparable year yet · 3 reportingSep 2025 · trailing 12-month earnings per share at 90, against 100 at the start · no comparable year yet · 3 reportingDec 2025 · trailing 12-month earnings per share at 113, against 100 at the start · up 32.4% on a year ago · 3 reportingMar 2026 · trailing 12-month earnings per share at 91, against 100 at the start · up 13.4% on a year ago · 4 reportingMar 2025 · too few reporting — 2 of the Chemicals - Speciality filed a comparable quarter, and three is the floor for a readingJun 2026 · too few reporting — 2 of the Chemicals - Speciality filed a comparable quarter, and three is the floor for a readingNot reported yet — earnings trail price by a quarter or two91 · Mar 26No earnings on file this far back — the price series reaches further than the filings doNO EARNINGS ON FILE
2005001000200020262025202420232022 2345333 TRAILING 12-MONTH EPS · 100 AT THE START0100113Mar 26Jun 2025 · trailing 12-month earnings per share at 100, against 100 at the start · no comparable year yet · 3 reportingSep 2025 · trailing 12-month earnings per share at 90, against 100 at the start · no comparable year yet · 3 reportingDec 2025 · trailing 12-month earnings per share at 113, against 100 at the start · up 32.4% on a year ago · 3 reportingMar 2026 · trailing 12-month earnings per share at 91, against 100 at the start · up 13.4% on a year ago · 4 reportingMar 2025 · too few reporting — 2 of the Chemicals - Speciality filed a comparable quarter, and three is the floor for a readingJun 2026 · too few reporting — 2 of the Chemicals - Speciality filed a comparable quarter, and three is the floor for a readingNot reported yet — earnings trail price by a quarter or two91No earnings on file this far back — the price series reaches further than the filings doNO EARNINGS ON FILE
Chemicals - Speciality, equal-weighted, based at 200 NIFTY 500, same base, same start trailing 12-month earnings per share rising falling

Both lines start at 200 in the same week, so the distance between them is the whole story: the sector line is an equal-weighted index of its 5 companies. The bars underneath are trailing 12-month earnings per share, one bar per reported quarter, each member rebased to 100 at the start and the sector taking the median — so a price line pulling away from flat bars is a re-rating, not earnings. A bar turns red when that figure is lower than the quarter before. Rules are fixed and applied identically everywhere on this site: ahead by 5% or more over three months, or behind by 20% or more over a year while earnings grew 20% or more. Hover any point to read both values and the gap. This is a description of what the numbers did, not advice.

03 · sector relative strength, before individual stocks

Is Chemicals - Speciality outperforming NIFTY 500?

Chemicals - Speciality has outperformed NIFTY 500 by 70.7% over the last 52 weeks. Over 13 weeks the gap is a lead of 26.8%. 2 of 3 covered companies currently beat NIFTY on Mansfield relative strength, so leadership inside the sector is selective. Jubilant Agri & Consumer Products Ltd is the strongest against the sector itself at -29%.

+26.8%Sector vs NIFTY 500 · 13 weeks
+70.7%Sector vs NIFTY 500 · 52 weeks
2/3Stocks leading NIFTY 500
0/1Stocks leading sector

Sector metric: 55.3 as of 2026-07-19 · NARROWING · rising.

The central tension: the companies with the most scale are not necessarily the companies creating the most change.

Start with scale. Then earnings trajectory. Then business quality. Only after those three agree should price leadership carry much weight.

Bottom line

Chemicals - Speciality has outperformed NIFTY 500 by 70.7% over 52 weeks and 26.8% over 13 weeks. 2 of 3 covered companies beat NIFTY on Mansfield relative strength, while 0 of 1 beat the sector itself. Jubilant Agri & Consumer Products Ltd leads with revenue of ₹1,891 crore, based on 5 of 5 comparable companies through Mar 2026.

Companies
5
complete canonical membership
Combined market value
₹15.3K Cr
Sudeep Pharma Ltd
Revenue growing
4/4
positive TTM year-on-year growth
Beating NIFTY 500
2/3
positive Mansfield relative strength
Comparing 5 of 5
04 · research priority, made explicit

4-Factor Sector Score

An additive sector-relative research score. The four displayed point contributions always equal the total: Growth & earnings (35), Capital efficiency (25), Valuation (20), and Relative strength (20). Missing or stale evidence is absorbed inside the affected factor, never applied as a hidden adjustment.

Growth & earnings · 35%Capital efficiency · 25%Valuation · 20%Relative strength · 20%
Jubilant Agri & Consumer Products Ltd has the strongest current balance of earnings trajectory, business quality, valuation and price confirmation, with 79.6% evidence confidence.
How this score is built, and what the marks mean

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Jubilant Agri & Consumer Products LtdJUBLCPL 61.3/100Mixed-positive evidence80% evidence TURNING 26.6/35 Revenue 21.1% · PAT 45.5% · OPM change 0 pp 88% evidence 16.9/25 ROCE 39.9% · OPM 7% 100% evidence 14.8/20 P/E 20.7× · PEG 0.79 50% evidence 3.0/20 RS sector -29% · RS bench -17.6% · 1Y -19%2 of 10 weeks ahead 70% evidence
Exact sum: 26.6 + 16.9 + 14.8 + 3 = 61.3 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -29% and the one-year return is -19%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
2Chembond Chemicals LtdCHEMBONDCH 60.0/100Mixed-positive evidence62% evidence 22.7/35 Revenue 18.4% · PAT 19.7% · OPM change 0.2 pp 95% evidence 14.8/25 ROCE 23.6% · OPM 13.1% 95% evidence 10.0/20 P/E 15.9× · PEG — 0% evidence 12.5/20 RS sector — · RS bench 31% · 1Y — 25% evidence
Exact sum: 22.7 + 14.8 + 10 + 12.5 = 60 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
3Anlon Healthcare LtdAHCL 54.4/100Thin evidence · provisional57% evidence TURNING 21.5/35 Revenue 95.4% · PAT 66.6% · OPM change -0.9 pp 95% evidence 12.9/25 ROCE 20.8% · OPM 17.8% 95% evidence 10.0/20 P/E 24.6× · PEG — 0% evidence 10.0/20 RS sector — · RS bench — · 1Y —10 of 12 weeks ahead 0% evidence
Exact sum: 21.5 + 12.9 + 10 + 10 = 54.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
4Sudeep Pharma LtdSUDEEPPHRM 46.7/100Mixed-negative evidence66% evidence BREAKING OUT 14.0/35 Revenue 19.6% · PAT 12.9% · OPM change -3 pp 88% evidence 17.7/25 ROCE 28.2% · OPM 34% 100% evidence 5.0/20 P/E 57.6× · PEG 4.75 50% evidence 10.0/20 RS sector — · RS bench — · 1Y —10 of 12 weeks ahead 0% evidence
Exact sum: 14 + 17.7 + 5 + 10 = 46.7 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression.
5Innovassynth Technologies (India) Ltd533315 44.8/100Thin evidence · provisional22% evidence TURNING 15.5/35 Revenue — · PAT 25.4% · OPM change — 15% evidence 6.8/25 ROCE -9.2% · OPM — 46% evidence 10.0/20 P/E — · PEG — 0% evidence 12.5/20 RS sector — · RS bench 59.9% · 1Y —3 of 3 weeks ahead 25% evidence
Exact sum: 15.5 + 6.8 + 10 + 12.5 = 44.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
05 · what price has already done

Market action

Jubilant Agri & Consumer Products Ltd has the strongest one-year price move in Chemicals - Speciality at -19%. Innovassynth Technologies (India) Ltd leads on Mansfield relative strength against NIFTY at +59.9%. 2 of 3 covered companies are above zero on that measure. Every line covers 313 weekly closes through 2026-07-31.

Price and relative strength

Every company, the sector's own index and NIFTY 500 all start level on the left edge of the window, so only the distance between the lines counts — the highest line has risen the most since then, and the chart at the top of this page is drawn the same way. It opens on one year; the buttons beside it stretch that to three or five.

06 · compare level, then change

Revenue Scale & Growth Durability

Jubilant Agri & Consumer Products Ltd has the highest Revenue among the 5 Chemicals - Speciality companies compared here, at ₹1,891 crore. Sudeep Pharma Ltd is next at ₹642 crore. Anlon Healthcare Ltd has the highest Revenue growth at 95.4%, so level and change sit with different companies. Its Revenue series carries 10 reported observations across the 20-quarter window.

What the numbers say: Jubilant Agri & Consumer Products Ltd is the scale leader at ₹1,891 crore, 194.5% ahead of Sudeep Pharma Ltd. Anlon Healthcare Ltd's growth is 95.4% from a ₹226 crore base, with 9 reported observations in the 20-quarter window. Treat the growth leader as an acceleration candidate, not as equally proven scale.

LeaderJubilant Agri & Consumer Products Ltd · ₹1,891 crore
Gap194.5% versus #2 · Sudeep Pharma Ltd
Persistence6/6 recent comparable periods
Coverage5/5 companies · 49 observations

Investor read: Jubilant Agri & Consumer Products Ltd is the scale benchmark; Anlon Healthcare Ltd is the acceleration watch. Promote the challenger only if growth persists and converts into margin and returns.

This conclusion weakens if: Jubilant Agri & Consumer Products Ltd's growth falls below Anlon Healthcare Ltd's for two consecutive comparable reports while operating margin also compresses.

Revenue is compared on a common reported-currency basis. Growth is year-on-year, so seasonality does not masquerade as progress.
Revenuelargest
2Sudeep Pharma Ltd SUDEEPPHRM₹642 Cr
3Chembond Chemicals Ltd CHEMBONDCH⚠ unverified₹347 Cr
4Anlon Healthcare Ltd AHCL⚠ unverified₹226 Cr
5Innovassynth Technologies (India) Ltd 533315 · older report₹0 Cr
Revenue growthfastest growers
1Anlon Healthcare Ltd AHCL⚠ unverified95%
3Sudeep Pharma Ltd SUDEEPPHRM20%
4Chembond Chemicals Ltd CHEMBONDCH⚠ unverified18%
Revenue · company comparison
5/5 level · 4/5 change

On every company-comparison chart on this page: solid lines show level, dotted lines show change when “Both” is selected, and a missing report breaks the line rather than being invented.

All-company data · latest reported quarter

In every all-company table on this page, each figure is the company’s latest single reported quarter. The rankings above them use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.

CompanyRevenueRevenue growthReported
Jubilant Agri & Consumer Products Ltd JUBLCPL₹485 Cr22%Mar 2026
Sudeep Pharma Ltd SUDEEPPHRM₹182 Cr15%Mar 2026
Anlon Healthcare Ltd AHCL⚠ unverified₹88 Cr163%Jun 2026
Chembond Chemicals Ltd CHEMBONDCH⚠ unverified₹86 Cr32%Jun 2026
Innovassynth Technologies (India) Ltd 533315₹0 CrSep 2025
Full 20-quarter history · every available company

Revenue · reported quarter history

Anlon Healthcare Ltd · AHCL⚠ unverified

₹38 Cr
₹24 Cr
₹9 Cr
₹49 Cr
₹33 Cr
₹52 Cr
₹36 Cr
₹51 Cr
₹88 Cr

Chembond Chemicals Ltd · CHEMBONDCH⚠ unverified

₹64 Cr
₹75 Cr
₹75 Cr
₹78 Cr
₹65 Cr
₹73 Cr
₹86 Cr
₹101 Cr
₹86 Cr

Innovassynth Technologies (India) Ltd · 533315

₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr

Jubilant Agri & Consumer Products Ltd · JUBLCPL

₹293 Cr
₹300 Cr
₹358 Cr
₹407 Cr
₹398 Cr
₹398 Cr
₹442 Cr
₹513 Cr
₹451 Cr
₹485 Cr

Sudeep Pharma Ltd · SUDEEPPHRM

₹114 Cr
₹149 Cr
₹116 Cr
₹158 Cr
₹125 Cr
₹163 Cr
₹172 Cr
₹182 Cr

Revenue growth · reported quarter history

Anlon Healthcare Ltd · AHCL⚠ unverified

-12%
116%
280%
4.0%
163%

Chembond Chemicals Ltd · CHEMBONDCH⚠ unverified

1.6%
-2.7%
15%
30%
32%

Jubilant Agri & Consumer Products Ltd · JUBLCPL

36%
33%
23%
26%
13%
22%

Sudeep Pharma Ltd · SUDEEPPHRM

9.7%
9.4%
48%
15%
07 · compare level, then change

Operating Economics & Margin Trend

Sudeep Pharma Ltd has the highest OPM among the 5 Chemicals - Speciality companies compared here, at 34%. Anlon Healthcare Ltd is next at 17.8%. Chembond Chemicals Ltd has the highest Margin change at +0.2 percentage points, so level and change sit with different companies. 4 of 5 companies report a comparable reading, the latest through Mar 2026.

What the numbers say: Sudeep Pharma Ltd leads opm at 34%; Chembond Chemicals Ltd leads margin change at +0.2 percentage points.

LeaderSudeep Pharma Ltd · 34%
Gap91% versus #2 · Anlon Healthcare Ltd
Persistence1/4 recent comparable periods
Coverage4/5 companies · 36 observations

Investor read: Sudeep Pharma Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current margin change signal.

Operating margin compares operating profit with revenue. Improvement is measured in percentage points, not percentage growth.
OPMhighest
1Sudeep Pharma Ltd SUDEEPPHRM34%
2Anlon Healthcare Ltd AHCL⚠ unverified18%
3Chembond Chemicals Ltd CHEMBONDCH⚠ unverified13%
Margin changefastest expanders
1Chembond Chemicals Ltd CHEMBONDCH⚠ unverified+0.2 pp
3Anlon Healthcare Ltd AHCL⚠ unverified−0.9 pp
4Sudeep Pharma Ltd SUDEEPPHRM−3.0 pp
Operating margin · company comparison
4/5 level · 4/5 change
All-company data · latest reported quarter
CompanyOPMMargin changeReported
Sudeep Pharma Ltd SUDEEPPHRM34%−3.0 ppMar 2026
Anlon Healthcare Ltd AHCL⚠ unverified18%−0.9 ppJun 2026
Chembond Chemicals Ltd CHEMBONDCH⚠ unverified13%+0.2 ppJun 2026
Jubilant Agri & Consumer Products Ltd JUBLCPL7.0%0.0 ppMar 2026
Full 20-quarter history · every available company

OPM · reported quarter history

Anlon Healthcare Ltd · AHCL⚠ unverified

18%
31%
6.2%
35%
19%
26%
35%
30%
18%

Chembond Chemicals Ltd · CHEMBONDCH⚠ unverified

11%
11%
19%
16%
13%
15%
14%
16%
13%

Jubilant Agri & Consumer Products Ltd · JUBLCPL

9.0%
7.0%
12%
10%
9.0%
7.0%
14%
12%
8.0%
7.0%

Sudeep Pharma Ltd · SUDEEPPHRM

38%
43%
34%
37%
35%
34%
35%
34%

Margin change · reported quarter history

Anlon Healthcare Ltd · AHCL⚠ unverified

+0.6 pp
−4.8 pp
+28.3 pp
−5.1 pp
−0.9 pp

Chembond Chemicals Ltd · CHEMBONDCH⚠ unverified

+1.5 pp
+4.1 pp
−4.9 pp
−0.1 pp
+0.2 pp

Jubilant Agri & Consumer Products Ltd · JUBLCPL

0.0 pp
0.0 pp
+2.0 pp
+2.0 pp
−1.0 pp
0.0 pp

Sudeep Pharma Ltd · SUDEEPPHRM

−2.9 pp
−9.0 pp
+1.0 pp
−3.0 pp
08 · compare level, then change

Profit Scale & Acceleration

Sudeep Pharma Ltd has the highest Net profit among the 5 Chemicals - Speciality companies compared here, at ₹175 crore. Jubilant Agri & Consumer Products Ltd is next at ₹128 crore. Anlon Healthcare Ltd has the highest Profit growth at 66.6%, so level and change sit with different companies.

What the numbers say: Sudeep Pharma Ltd leads with ₹175 crore of TTM profit, 36.7% above Jubilant Agri & Consumer Products Ltd. Anlon Healthcare Ltd shows 66.6% growth from a ₹34 crore profit base. Compare the size of the base and persistence before ranking acceleration above profit scale.

LeaderSudeep Pharma Ltd · ₹175 crore
Gap36.7% versus #2 · Jubilant Agri & Consumer Products Ltd
Persistence2/4 recent comparable periods
Coverage5/5 companies · 49 observations

Investor read: Sudeep Pharma Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current profit growth signal.

Net profit is the residual after operating costs, interest and tax. Growth off a loss or near-zero base is excluded from the fastest-grower rank.
Net profitlargest
1Sudeep Pharma Ltd SUDEEPPHRM₹175 Cr
3Chembond Chemicals Ltd CHEMBONDCH⚠ unverified₹38 Cr
4Anlon Healthcare Ltd AHCL⚠ unverified₹34 Cr
5Innovassynth Technologies (India) Ltd 533315 · older report₹-5 Cr
Profit growthfastest growers
1Anlon Healthcare Ltd AHCL⚠ unverified67%
3Chembond Chemicals Ltd CHEMBONDCH⚠ unverified20%
4Sudeep Pharma Ltd SUDEEPPHRM13%
Net profit · company comparison
5/5 level · 4/5 change
All-company data · latest reported quarter
CompanyNet profitProfit growthReported
Sudeep Pharma Ltd SUDEEPPHRM₹49 Cr11%Mar 2026
Jubilant Agri & Consumer Products Ltd JUBLCPL₹20 Cr25%Mar 2026
Chembond Chemicals Ltd CHEMBONDCH⚠ unverified₹10 Cr52%Jun 2026
Anlon Healthcare Ltd AHCL⚠ unverified₹8 Cr133%Jun 2026
Innovassynth Technologies (India) Ltd 533315₹-5 Cr-57%Sep 2025
Full 20-quarter history · every available company

Net profit · reported quarter history

Anlon Healthcare Ltd · AHCL⚠ unverified

₹5 Cr
₹3 Cr
₹-2 Cr
₹17 Cr
₹4 Cr
₹9 Cr
₹5 Cr
₹11 Cr
₹8 Cr

Chembond Chemicals Ltd · CHEMBONDCH⚠ unverified

₹6 Cr
₹7 Cr
₹10 Cr
₹9 Cr
₹6 Cr
₹7 Cr
₹10 Cr
₹12 Cr
₹10 Cr

Innovassynth Technologies (India) Ltd · 533315

₹-1 Cr
₹-4 Cr
₹4 Cr
₹-5 Cr
₹-1 Cr
₹-4 Cr
₹9 Cr
₹-6 Cr
₹-6 Cr
₹3 Cr
₹4 Cr
₹-7 Cr
₹-5 Cr

Jubilant Agri & Consumer Products Ltd · JUBLCPL

₹-21 Cr
₹22 Cr
₹26 Cr
₹25 Cr
₹21 Cr
₹16 Cr
₹44 Cr
₹42 Cr
₹22 Cr
₹20 Cr

Sudeep Pharma Ltd · SUDEEPPHRM

₹33 Cr
₹49 Cr
₹29 Cr
₹44 Cr
₹31 Cr
₹47 Cr
₹48 Cr
₹49 Cr

Profit growth · reported quarter history

Anlon Healthcare Ltd · AHCL⚠ unverified

-22%
260%
-34%
133%

Chembond Chemicals Ltd · CHEMBONDCH⚠ unverified

12%
4.5%
-2.6%
34%
52%

Innovassynth Technologies (India) Ltd · 533315

121%
-57%

Jubilant Agri & Consumer Products Ltd · JUBLCPL

-27%
69%
68%
4.8%
25%

Sudeep Pharma Ltd · SUDEEPPHRM

-6.1%
-4.1%
66%
11%
09 · compare level, then change

Return On Capital Employed

Jubilant Agri & Consumer Products Ltd has the highest ROCE among the 5 Chemicals - Speciality companies compared here, at 39.9%. Sudeep Pharma Ltd is next at 28.2%. The same company also holds the highest ROCE change, at +0.1 percentage points. 5 of 5 companies report a comparable reading, the latest through Mar 2026.

What the numbers say: Jubilant Agri & Consumer Products Ltd leads ROCE at 39.9%, 11.7 percentage points above Sudeep Pharma Ltd. Jubilant Agri & Consumer Products Ltd has the strongest latest improvement at +0.1 percentage points. Read the leader beside the density of its reported history: a sparse high return is a candidate; a repeated high return is evidence of durability.

LeaderJubilant Agri & Consumer Products Ltd · 39.9%
Gap41.5% versus #2 · Sudeep Pharma Ltd
Persistence2/2 recent comparable periods
Coverage5/5 companies · 30 observations

Investor read: Jubilant Agri & Consumer Products Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current roce change signal.

ROCE asks how much operating return the business earns on the capital employed. Direction matters, but a single exceptional year should not be mistaken for durability.
ROCEhighest
2Sudeep Pharma Ltd SUDEEPPHRM28%
3Chembond Chemicals Ltd CHEMBONDCH⚠ unverified24%
4Anlon Healthcare Ltd AHCL⚠ unverified21%
5Innovassynth Technologies (India) Ltd 533315 · older report-9.2%
ROCE changefastest improvers
2Chembond Chemicals Ltd CHEMBONDCH⚠ unverified−2.2 pp
3Anlon Healthcare Ltd AHCL⚠ unverified−7.8 pp
4Innovassynth Technologies (India) Ltd 533315 · older report−7.9 pp
5Sudeep Pharma Ltd SUDEEPPHRM−15.0 pp
Return on capital · company comparison
5/5 level · 5/5 change
All-company data · latest reported quarter
CompanyROCEROCE changeReported
Jubilant Agri & Consumer Products Ltd JUBLCPL35%+0.1 ppMar 2026
Chembond Chemicals Ltd CHEMBONDCH⚠ unverified25%−2.2 ppJun 2026
Sudeep Pharma Ltd SUDEEPPHRM21%−15.0 ppMar 2026
Anlon Healthcare Ltd AHCL⚠ unverified17%−7.8 ppJun 2026
Full 20-quarter history · every available company

ROCE · reported quarter history

Anlon Healthcare Ltd · AHCL⚠ unverified

7.9%
25%
24%
15%
29%
17%

Chembond Chemicals Ltd · CHEMBONDCH⚠ unverified

5.6%
4.9%
5.6%
10%
13%
27%
19%
27%
19%
26%
21%
25%

Jubilant Agri & Consumer Products Ltd · JUBLCPL

15%
35%
46%
38%
47%
35%

Sudeep Pharma Ltd · SUDEEPPHRM

30%
36%
26%
24%
37%
21%

ROCE change · reported quarter history

Anlon Healthcare Ltd · AHCL⚠ unverified

+16.0 pp
−7.8 pp

Chembond Chemicals Ltd · CHEMBONDCH⚠ unverified

0.0 pp
+5.2 pp
+6.9 pp
+16.8 pp
−7.7 pp
+1.8 pp
−2.2 pp

Jubilant Agri & Consumer Products Ltd · JUBLCPL

+19.7 pp
+0.1 pp

Sudeep Pharma Ltd · SUDEEPPHRM

+6.7 pp
−15.0 pp
10 · compare level, then change

Valuation Against Growth & Quality

Jubilant Agri & Consumer Products Ltd has the lowest PEG among the 5 Chemicals - Speciality companies compared here, at 0.79×. Sudeep Pharma Ltd is next at 4.75×. Chembond Chemicals Ltd has the lowest P/E at 15.9×, so level and change sit with different companies. 2 of 5 companies report a comparable reading, the latest through Mar 2026.

What the numbers say: Jubilant Agri & Consumer Products Ltd has the lowest comparable PEG at 0.79×, 83.4% below Sudeep Pharma Ltd. Only 2 of 5 companies have earnings and growth steady enough for the ratio to mean anything, so no broad “cheapest stock” conclusion is defensible unless the current multiple, own-history position and growth durability agree.

LeaderJubilant Agri & Consumer Products Ltd · 0.79×
Gap83.4% versus #2 · Sudeep Pharma Ltd
Persistence0/5 recent comparable periods
Coverage2/5 companies · 2 observations

Investor read: Treat valuation as permission to investigate, never as a standalone reason to buy.

This conclusion weakens if: The next two comparable reports reverse the current p/e signal.

PEG is shown only when earnings are positive and three-year EPS growth is between 5% and 60%. It is recomputed consistently as the trailing P/E divided by that growth rate — reported earnings, never an expected-earnings multiple. On Indian companies it is shown only where the two data feeds agreed. Where any of that fails the ratio is left out rather than printed: a P/E divided by a loss, or by growth measured off a tiny base, is a number that looks precise and means nothing.
PEGlowest PEG
2Sudeep Pharma Ltd SUDEEPPHRM4.8
P/Elowest P/E
1Chembond Chemicals Ltd CHEMBONDCH⚠ unverified15.9
3Anlon Healthcare Ltd AHCL⚠ unverified24.6
4Sudeep Pharma Ltd SUDEEPPHRM57.6
Valuation · company comparison
2/5 level · 4/5 change
All-company data · latest reported quarter
CompanyPEGP/EReported
Sudeep Pharma Ltd SUDEEPPHRM4.835.6Mar 2026
Jubilant Agri & Consumer Products Ltd JUBLCPL0.818.5Mar 2026
Innovassynth Technologies (India) Ltd 533315173.1Sep 2025
Anlon Healthcare Ltd AHCL⚠ unverified29.6Jun 2026
Chembond Chemicals Ltd CHEMBONDCH⚠ unverified16.7Jun 2026
Full 20-quarter history · every available company

PEG · reported quarter history

Jubilant Agri & Consumer Products Ltd · JUBLCPL

0.8

Sudeep Pharma Ltd · SUDEEPPHRM

4.8

P/E · reported quarter history

Anlon Healthcare Ltd · AHCL⚠ unverified

25.8
23.2
20.8
29.6

Chembond Chemicals Ltd · CHEMBONDCH⚠ unverified

19.3
19.7
8.2
16.7

Innovassynth Technologies (India) Ltd · 533315

63.0
56.3
1,824.0
1,837.0
165.1
173.1

Jubilant Agri & Consumer Products Ltd · JUBLCPL

21.6
29.3
36.3
27.3
18.5

Sudeep Pharma Ltd · SUDEEPPHRM

42.1
35.6
11 · before the conclusion, check the blind spots

What can make this comparison misleading?

This Chemicals - Speciality comparison names 7 specific ways its own evidence can mislead, all listed below. 1 of the 5 companies reports on an older date than the sector's freshest reporters, so its rank is marked stale. 2 draw at least one figure from a second feed with too little overlap to cross-check.

Keep these limits visible

  • A high growth rate can be a low-base artefact. The page keeps level and change separate for that reason.
  • A high ROCE can be temporary or flattered by a small capital base. Read it beside margin, cash conversion and reinvestment.
  • The 4-Factor Sector Score ranks research priority, not portfolio action. Management quality, catalysts and risks need equally fresh evidence before capital is deployed.
  • An “all companies” line chart preserves completeness, but rank changes should be checked against reporting dates before drawing a conclusion.
  • 1 company has an older fundamental reporting date than the sector’s freshest reporters; its rank carries a stale marker.
  • 2 companies draw at least one figure from a second data feed with too little overlapping history to cross-check against the primary source; they are marked unverified wherever those figures appear.
  • Thin comparisons: Valuation have fewer than three usable current readings.
12 · evidence and freshness

How was this comparison built?

This comparison is built from the reported filings of 5 Chemicals - Speciality companies, normalized to a common ₹ scale and a shared quarter axis of up to 20 quarters each. Fundamentals run through Jun 2026 and market data through 2026-07-31. A second data feed fills gaps only after identity and scale reconciliation, and missing observations are never interpolated.

FundamentalsThrough Jun 2026 · up to 20 quarters per company
Market dataThrough 2026-07-31 · weekly price and relative-strength history
Derived metricsGrowth, changes and PEG are calculated only when their inputs are comparable.
Score confidenceMissing and stale evidence reduces confidence and pulls the 0–100 research-priority score toward neutral.
Source standing2 cross-checked · 3 unverified · 0 withheld, of 5 graded companies.
How a second data feed is admitted, and what happens when it disagrees

A second feed is read only after its reported income is matched against the primary source on at least three overlapping periods. Where the two agree the figures fill silently. Where there is too little shared history to compare, the figures are still drawn — they are the only evidence there is — and marked ⚠ unverified everywhere they appear. Where the two are known to disagree, nothing from the second feed is drawn and the affected company is named under the chart it is missing from.

13 · questions investors ask, short speakable answers

Chemicals - Speciality company comparison FAQs

These 23 answers restate the Chemicals - Speciality comparison above in question form. Every one is computed from the same 5 companies and the same reported filings as the rankings and charts, current through Jun 2026. Price and relative-strength answers run through 2026-07-31. Nothing here is estimated, and none of it is a recommendation.

Is the Chemicals - Speciality sector outperforming NIFTY 500?

Chemicals - Speciality has outperformed NIFTY 500 by 70.7% over 52 weeks and 26.8% over 13 weeks. 2 of 3 covered companies beat NIFTY on Mansfield relative strength, while 0 of 1 beat the sector itself.

Which Chemicals - Speciality company is largest by revenue?

Jubilant Agri & Consumer Products Ltd leads with revenue of ₹1,891 crore, based on 5 of 5 comparable companies through Mar 2026.

Which Chemicals - Speciality company is growing fastest?

Anlon Healthcare Ltd has the fastest current revenue growth at 95.4%, across 4 of 5 comparable companies.

Which Chemicals - Speciality company has the strongest 4-Factor Sector Score?

Jubilant Agri & Consumer Products Ltd ranks first at 61.3/100 with 79.6% evidence confidence. The score prioritizes research; it is not a buy recommendation.

Which Chemicals - Speciality company has the lowest comparable PEG?

Jubilant Agri & Consumer Products Ltd has the lowest comparable PEG at 0.79, among 2 of 5 companies whose earnings and growth are steady enough for the ratio to mean anything.

How much history does this Chemicals - Speciality comparison include?

The page compares up to 20 reported quarters per company for fundamentals, returns and valuation, ending Jun 2026. Missing observations remain blank rather than being estimated.

How is the 4-Factor Sector Score calculated?

The four visible contributions add directly: growth and earnings up to 35 points, capital efficiency up to 25, valuation up to 20, and relative strength up to 20. Missing or stale evidence moves only the affected contribution toward neutral.

What is the Nifty Chemicals - Speciality index?

The Nifty Chemicals - Speciality index tracks India's listed Chemicals - Speciality companies as a single basket. This page follows the same 5 companies and equal-weights them, so every company's weekly return counts once whatever it is worth, and the reading belongs to the Chemicals - Speciality sector rather than to its largest constituent. Figures are as of Jun 2026.

Which are the best Chemicals - Speciality stocks in India?

Ranked by this page's four-factor score, Jubilant Agri & Consumer Products Ltd places first among 5 listed Chemicals - Speciality companies, followed by Chembond Chemicals Ltd. That is a ranking of published data — earnings, quality, valuation and market behaviour as of Jun 2026 — and not a recommendation; Sector Alpha is not registered with SEBI as an investment adviser.

How many Chemicals - Speciality stocks are listed in India?

This comparison covers 5 listed Chemicals - Speciality companies in India, each above the size floor the site applies, with 20 quarters of reported figures per company where the filings exist. The full ranked list is on this page, as of Jun 2026.

Which Chemicals - Speciality company is the biggest?

Jubilant Agri & Consumer Products Ltd is the largest, with trailing-twelve-month revenue of ₹1,891 crore, ahead of Sudeep Pharma Ltd at ₹642 crore. That covers 5 of 5 companies with comparable reporting through Mar 2026.

Which Chemicals - Speciality company has the best profit margins?

Sudeep Pharma Ltd has the highest operating margin at 34%, from 4 of 5 comparable companies. Chembond Chemicals Ltd shows the biggest recent improvement, at +0.2 percentage points. A high margin matters most when it is holding or rising, not when it is peaking.

Which Chemicals - Speciality company makes the most profit?

Sudeep Pharma Ltd earns the most, at ₹175 crore of trailing-twelve-month net profit, from 5 of 5 comparable companies. Anlon Healthcare Ltd has the fastest profit growth at 66.6%, though growth off a small or recovering profit base overstates how much has actually changed.

Which Chemicals - Speciality company earns the highest return on capital?

Jubilant Agri & Consumer Products Ltd leads on return on capital employed at 39.9%, across 5 of 5 companies. Read it beside the length of its reported history: a high return that repeats for years is evidence of a durable business, while a single high reading can be a small capital base or one good year.

Which Chemicals - Speciality stock is the cheapest?

On PEG — where a LOWER number is cheaper — Jubilant Agri & Consumer Products Ltd screens cheapest at 0.79×. Only 2 of 5 companies have earnings and growth steady enough for the ratio to mean anything, so this is not a sector-wide "cheapest stock" verdict. Cheap on a multiple is a reason to investigate, never a reason to buy on its own.

Is the Chemicals - Speciality sector beating the market?

Chemicals - Speciality has outperformed NIFTY 500 by 70.7% over the last 52 weeks and 26.8% over 13 weeks, measured on an equal-weight index of its current members. Inside the sector, 2 of 3 covered companies are beating the market on their own. Sector strength does not transfer evenly to every stock in it.

Which Chemicals - Speciality stock has the strongest price momentum?

Innovassynth Technologies (India) Ltd has the strongest relative strength against NIFTY 500. Relative strength answers last, after growth, quality and valuation: price can move well before the fundamentals confirm it, and sometimes without them confirming at all.

Which Chemicals - Speciality company scores highest for research priority?

Jubilant Agri & Consumer Products Ltd scores 61.3 out of 100 with 79.6% evidence confidence, from 26.6 points on growth and earnings, 16.9 on capital efficiency, 14.8 on valuation and 3 on relative strength. This ranks what deserves work next. It is not a buy recommendation, and management quality, catalysts and risk still need separate research.

How many Chemicals - Speciality companies does this comparison cover, and over what period?

It compares 5 listed companies over up to 20 reported quarters of fundamentals, ending Jun 2026, plus weekly price and relative-strength history. Membership is the full sector list — nothing is dropped for having thin data.

What is the total market cap of the Chemicals - Speciality sector?

The 5 Chemicals - Speciality companies on this page carry ₹15,281 crore of combined market value. Sudeep Pharma Ltd is the largest at ₹9,951 crore, about 65% of the sector's total on its own. Market value moves with price, so this reading is dated 2026-08-05.

How is the Chemicals - Speciality sector performing?

2 of the 3 covered Chemicals - Speciality companies are beating NIFTY 500 on Mansfield relative strength. The sector itself is 70.7% ahead of NIFTY 500 over 52 weeks on an equal-weight index of its current members. Readings are as of 2026-08-05.

Why are some values on this page blank?

A blank means that company did not report a comparable figure for that period, so nothing is shown. Missing observations are never interpolated, carried forward, or replaced with a similar-looking accounting line, and a company with missing evidence has its research score pulled toward neutral rather than being scored as bad.

Is this investment advice?

No. Every figure here is a deterministic calculation from reported company filings and market data, published for research. It contains no recommendation to buy or sell any security, does not account for your circumstances, and is not a substitute for advice from a licensed adviser.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI